Contineum Therapeutics (CTNM) News Today $3.85 -0.07 (-1.79%) As of 09:43 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CTNM Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Contineum Therapeutics, Inc. (NASDAQ:CTNM) Receives Average Recommendation of "Buy" from AnalystsJuly 15 at 2:28 AM | marketbeat.comContineum Therapeutics (NASDAQ:CTNM) Shares Down 2.7% - What's Next?July 12 at 4:37 AM | marketbeat.comContineum Therapeutics stock falls after trial data delayJune 25, 2025 | investing.comContineum Therapeutics Shares Drop After Delay in Trial Data ReleaseJune 25, 2025 | msn.comContineum Therapeutics Provides Update on Phase 1b Positron Emission Tomography (PET) Trial of PIPE-791June 25, 2025 | businesswire.comContineum Therapeutics (NASDAQ:CTNM) Coverage Initiated at William BlairJune 20, 2025 | marketbeat.comContineum Therapeutics, Inc. (NASDAQ:CTNM) Receives Consensus Rating of "Buy" from AnalystsJune 20, 2025 | marketbeat.comSquarepoint Ops LLC Trims Position in Contineum Therapeutics, Inc. (NASDAQ:CTNM)May 28, 2025 | marketbeat.comPolar Capital Holdings Plc Reduces Stock Position in Contineum Therapeutics, Inc. (NASDAQ:CTNM)May 19, 2025 | marketbeat.comContineum Therapeutics to Present at the 2025 RBC Capital Markets Global Healthcare ConferenceMay 15, 2025 | businesswire.comContineum Therapeutics Reports Q1 2025 Financial ResultsMay 14, 2025 | tipranks.comContineum Therapeutics Reports First-Quarter 2025 Financial Results; Affirms Key Clinical Development MilestonesMay 14, 2025 | businesswire.comContineum Therapeutics (CTNM) Expected to Announce Earnings on ThursdayMay 10, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Buys Shares of 125,995 Contineum Therapeutics, Inc. (NASDAQ:CTNM)May 8, 2025 | marketbeat.comGeode Capital Management LLC Purchases 59,732 Shares of Contineum Therapeutics, Inc. (NASDAQ:CTNM)April 30, 2025 | marketbeat.comContineum Therapeutics Appoints Timothy Watkins, M.D., M.Sc., as Chief Medical Officer and Head of DevelopmentApril 30, 2025 | finance.yahoo.comWe're Not Very Worried About Contineum Therapeutics' (NASDAQ:CTNM) Cash Burn RateApril 23, 2025 | finance.yahoo.comNorges Bank Acquires Shares of 169,729 Contineum Therapeutics, Inc. (NASDAQ:CTNM)April 14, 2025 | marketbeat.comContineum Therapeutics Rings the Nasdaq Stock Market Closing BellApril 10, 2025 | nasdaq.comContineum Therapeutics Rings the Closing BellApril 10, 2025 | nasdaq.comADAR1 Capital Management LLC Raises Stock Position in Contineum Therapeutics, Inc. (NASDAQ:CTNM)April 9, 2025 | marketbeat.comContineum Therapeutics, Inc. (NASDAQ:CTNM) Given Average Recommendation of "Buy" by BrokeragesApril 8, 2025 | marketbeat.comContineum Therapeutics Announces Appointment of Diego Miralles, M.D. to Its Board of DirectorsMarch 17, 2025 | finance.yahoo.comContineum Therapeutics Appoints Diego Miralles to BoardMarch 17, 2025 | tipranks.comContineum initiated with a Buy at JonesResearchMarch 15, 2025 | markets.businessinsider.comContineum Therapeutics (NASDAQ:CTNM) Now Covered by Jones TradingMarch 14, 2025 | marketbeat.comJones Trading Initiates Coverage of Contineum Therapeutics (CTNM) with Buy RecommendationMarch 14, 2025 | msn.comInstitutional investors in Contineum Therapeutics, Inc. (NASDAQ:CTNM) have had a wonderful week after share price increased 24%March 13, 2025 | finance.yahoo.comContineum Therapeutics to Present at the Stifel 2025 Virtual CNS ForumMarch 12, 2025 | businesswire.comMorgan Stanley Reiterates "Overweight" Rating for Contineum Therapeutics (NASDAQ:CTNM)March 8, 2025 | marketbeat.comRobert W. Baird Issues Pessimistic Forecast for Contineum Therapeutics (NASDAQ:CTNM) Stock PriceMarch 8, 2025 | marketbeat.comContineum assumed with an Overweight at Morgan StanleyMarch 7, 2025 | markets.businessinsider.comContineum price target lowered to $16 from $32 at BairdMarch 7, 2025 | markets.businessinsider.comContineum reports Q4 EPS (56c), consensus (44c)March 6, 2025 | markets.businessinsider.comContineum Therapeutics Reports Fourth-Quarter 2024 Financial Results; Affirms Key Clinical Development MilestonesMarch 6, 2025 | businesswire.comContineum initiates dosing in phase 1b Chronic Pain trial of PIPE-791March 4, 2025 | markets.businessinsider.comContineum Therapeutics Initiates Patient Dosing in Phase 1b Chronic Pain Trial of PIPE-791March 4, 2025 | finance.yahoo.comContineum Therapeutics (CTNM) Expected to Announce Quarterly Earnings on WednesdayFebruary 21, 2025 | marketbeat.comContineum Therapeutics, Inc. Class A Common Stock (CTNM) Institutional HoldingsFebruary 19, 2025 | nasdaq.comContineum Therapeutics, Inc. (NASDAQ:CTNM) Short Interest UpdateFebruary 18, 2025 | marketbeat.comContineum Therapeutics (CTNM) Projected to Post Earnings on WednesdayJanuary 29, 2025 | marketbeat.comContineum Therapeutics' (CTNM) Outperform Rating Reiterated at Royal Bank of CanadaJanuary 9, 2025 | marketbeat.comContineum Therapeutics Completes Enrollment in Phase 2 PIPE-307 VISTA Trial for the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)January 8, 2025 | businesswire.comFranklin Resources Inc. Buys 820,542 Shares of Contineum Therapeutics, Inc. (NASDAQ:CTNM)December 19, 2024 | marketbeat.comContineum initiates patient dosing in Phase 1B PET trialDecember 18, 2024 | markets.businessinsider.comContineum Therapeutics Initiates Patient Dosing in Phase 1b Positron Emission Tomography (PET) Trial of PIPE-791December 16, 2024 | finance.yahoo.comContineum Therapeutics Inc Class A Common StockDecember 11, 2024 | morningstar.comMFmr LLC Buys 373,327 Shares of Contineum Therapeutics, Inc. (NASDAQ:CTNM)December 11, 2024 | marketbeat.comSuvretta Capital Management LLC Sells 333,334 Shares of Contineum Therapeutics, Inc. (NASDAQ:CTNM)November 29, 2024 | marketbeat.comContineum Therapeutics, Inc. (CTNM)November 27, 2024 | finance.yahoo.com Get Contineum Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CTNM and its competitors with MarketBeat's FREE daily newsletter. Email Address CTNM Media Mentions By Week CTNM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CTNM News Sentiment▼1.280.99▲Average Medical News Sentiment CTNM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CTNM Articles This Week▼31▲CTNM Articles Average Week Get Contineum Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CTNM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TECX News Today SLDB News Today ITOS News Today ETON News Today ALT News Today CMPX News Today CYRX News Today RVNC News Today VIGL News Today CTOR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CTNM) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Contineum Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Contineum Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CTNM Stock Alerts